NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 309 filers reported holding NOVOCURE LTD in Q1 2022. The put-call ratio across all filers is 1.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $17,597,361 | -47.7% | 1,089,620 | +34.4% | 0.00% | -33.3% |
Q2 2023 | $33,637,828 | +15.9% | 810,550 | +68.0% | 0.00% | 0.0% |
Q1 2023 | $29,023,245 | -19.6% | 482,594 | -1.9% | 0.00% | -25.0% |
Q4 2022 | $36,091,427 | -49.2% | 492,044 | -47.3% | 0.00% | -60.0% |
Q3 2022 | $70,981,000 | -0.7% | 934,213 | -9.2% | 0.01% | +11.1% |
Q2 2022 | $71,469,000 | +18.2% | 1,028,338 | +40.9% | 0.01% | +12.5% |
Q1 2022 | $60,451,000 | -2.6% | 729,649 | -11.7% | 0.01% | 0.0% |
Q4 2021 | $62,046,000 | -39.6% | 826,414 | -6.5% | 0.01% | -42.9% |
Q3 2021 | $102,716,000 | -46.2% | 884,185 | +2.8% | 0.01% | -44.0% |
Q2 2021 | $190,746,000 | +16.9% | 859,912 | -30.4% | 0.02% | +4.2% |
Q1 2021 | $163,233,000 | -30.2% | 1,234,928 | -8.6% | 0.02% | -33.3% |
Q4 2020 | $233,718,000 | +58.8% | 1,350,654 | +2.1% | 0.04% | +28.6% |
Q3 2020 | $147,217,000 | +85.1% | 1,322,589 | -1.4% | 0.03% | +55.6% |
Q2 2020 | $79,519,000 | -4.2% | 1,340,954 | +8.7% | 0.02% | -21.7% |
Q1 2020 | $83,045,000 | -27.2% | 1,233,217 | -8.8% | 0.02% | -14.8% |
Q4 2019 | $114,008,000 | +525.1% | 1,352,896 | +454.6% | 0.03% | +440.0% |
Q3 2019 | $18,239,000 | +182.7% | 243,919 | +139.1% | 0.01% | +150.0% |
Q2 2019 | $6,452,000 | +56.0% | 102,027 | +18.8% | 0.00% | +100.0% |
Q1 2019 | $4,137,000 | -37.5% | 85,877 | -56.6% | 0.00% | -50.0% |
Q4 2018 | $6,619,000 | -50.7% | 197,704 | -22.9% | 0.00% | -33.3% |
Q3 2018 | $13,434,000 | +62.9% | 256,408 | -2.7% | 0.00% | +50.0% |
Q2 2018 | $8,247,000 | +48.6% | 263,506 | +3.5% | 0.00% | 0.0% |
Q1 2018 | $5,549,000 | +14.0% | 254,562 | +5.7% | 0.00% | +100.0% |
Q4 2017 | $4,866,000 | +8.2% | 240,920 | +6.3% | 0.00% | 0.0% |
Q3 2017 | $4,498,000 | +52.2% | 226,624 | +32.7% | 0.00% | 0.0% |
Q2 2017 | $2,955,000 | +68.9% | 170,777 | -20.9% | 0.00% | – |
Q1 2017 | $1,750,000 | -46.1% | 215,994 | -47.7% | 0.00% | -100.0% |
Q4 2016 | $3,244,000 | +647.5% | 413,352 | +712.7% | 0.00% | – |
Q3 2016 | $434,000 | -5.7% | 50,859 | +29.1% | 0.00% | – |
Q2 2016 | $460,000 | -88.0% | 39,410 | -85.1% | 0.00% | -100.0% |
Q1 2016 | $3,828,000 | -60.2% | 264,385 | -38.5% | 0.00% | -66.7% |
Q4 2015 | $9,619,000 | – | 430,177 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |